Cargando…
Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant
Autores principales: | Patel, Dilan A., Mendoza, Karina A., Chen, Heidi, Engelhardt, Brian G., Savani, Bipin N., Goodman, Stacey A., Warner, Jeremy, Kassim, Adetola A., Byrne, Michael, Chinratanalab, Wichai, Greer, John P., Hunt, Carole, Jagasia, Madan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891906/ https://www.ncbi.nlm.nih.gov/pubmed/33643509 http://dx.doi.org/10.14740/jh761 |
Ejemplares similares
-
Six Month Freedom from Treatment Failure is an Important Endpoint for Acute Graft-Versus-Host Disease Clinical Trials
por: Sengsayadeth, Salyka, et al.
Publicado: (2013) -
New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide
por: Mangan, Brendan L., et al.
Publicado: (2020) -
Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience
por: Sheth, Vipul, et al.
Publicado: (2019) -
Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
por: Eplin, Dwight D., et al.
Publicado: (2019) -
Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC)
por: De Giglio, Andrea, et al.
Publicado: (2022)